Welcomes Cathy Steiner as Independent Director
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the voting results from the company’s Annual and Special Meeting of its Shareholders held on Wednesday, June 9, 2021.
All of management’s nominees for election were duly elected as directors of the company by the shareholders presented or represented by proxy at the meeting. A total of 56,098,112 of the 109,527,690 common shares outstanding, or 51.22%, were voted at the meeting. The results of the vote were reported to the meeting by Computershare, which acted as scrutineer at the meeting, as follows:
“I would like to take this opportunity to welcome Cathy Steiner to our Board of Directors,” said Paul Cataford, Chairman of the Board of Directors. “With over 20 years of experience as an investment banker and financial and capital markets advisor for healthcare companies, we are confident that Cathy will be a strong contributor to the board and its committees as an independent director. She joins Titan at a very exciting time, as we advance our Enos™ system toward clinical studies.”
The appointment of BDO Canada LLP as independent auditors of the company was approved by shareholders (with 52,008,750 votes for and 4,089,761 votes withheld) in respect of the motion.
Renewal of the Stock Option Plan was approved by shareholders (with 15,852,067 votes for and 7,290,430 votes withheld) in respect of the motion.
Approval of amendments to the Stock Option Plan for the provision of incentive stock options was approved by shareholders (with 15,496,101 votes for and 7,646,396 votes withheld) in respect of the motion.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.
